Effects of an antisense oligonucleotide to pronociceptin and long-term prevention of morphine actions by nociceptin

被引:13
作者
Candeletti, S [1 ]
Ferri, S [1 ]
机构
[1] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy
关键词
nociceptin; morphine; antisense oligodeoxynucleotide; tail-flick; body temperature; rat;
D O I
10.1016/S0196-9781(00)00249-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To further characterize the anti-opioid action of the neuropeptide nociceptin, we examined the effects of the repeated intracerebroventricular (i.c.v.) treatment (once daily for 4 days) with an antisense oligodeoxynucleotide complementary to pronociceptin mRNA, in the rat. We also investigated possible changes of the antinociceptive and hyperthermic effects induced by the i.c.v. administration of morphine, in rats i.c.v. pretreated with nociceptin 3 h before. The pretreatment with the antisense oligodeoxynucleotide, but not with a mismatched sequence (used as a control), caused an increase in spontaneous locomotor activity and produced a potentiation of the antinociceptive effect of a submaximal dose of i.c.v. morphine (1 mu g/rat). The i.c.v. pretreatment with nociceptin (2 nmol/rat, 3 h before) prevented both the antinociceptive and the hyperthermic effects of morphine (10 mu g/rat i.c.v.). These results strengthen the hypothesis of an anti-opioid action of nociceptin at supraspinal level and suggest that the neuropeptide may exert long-term modulatory effects. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1119 / 1124
页数:6
相关论文
共 46 条
[1]   [Phe1ψ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor [J].
Butour, JL ;
Moisand, C ;
Mollereau, C ;
Meunier, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 349 (01) :R5-R6
[2]   Supraspinal and spinal effects of [Phe1ψ(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat [J].
Candeletti, S ;
Guerrini, R ;
Calò, G ;
Romualdi, P ;
Ferri, S .
LIFE SCIENCES, 1999, 66 (03) :257-264
[3]   Evidence that [Phe1 ψ (CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord [J].
Carpenter, KJ ;
Dickenson, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (05) :949-951
[4]   Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro [J].
Connor, M ;
Vaughan, CW ;
Chieng, B ;
Christie, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (08) :1614-1618
[5]   The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line [J].
Connor, M ;
Yeo, A ;
Henderson, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :205-207
[6]   Progress in antisense oligonucleotide therapeutic [J].
Crooke, ST ;
Bennett, CF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :107-129
[7]   Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ [J].
Devine, DP ;
Taylor, L ;
Reinscheid, RK ;
Monsma, FJ ;
Civelli, O ;
Akil, H .
NEUROCHEMICAL RESEARCH, 1996, 21 (11) :1387-1396
[8]  
Du LN, 1998, ACUPUNCTURE ELECTRO, V23, P1
[9]   Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro [J].
Faber, ESL ;
Chambers, JP ;
Evans, RH ;
Henderson, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (02) :189-190
[10]   Nociceptin stimulates locomotion and exploratory behaviour in mice [J].
Florin, S ;
Suaudeau, C ;
Meunier, JC ;
Costentin, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 317 (01) :9-13